Last reviewed · How we verify
microneedling with topical human insulin solution. — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
microneedling with topical human insulin solution. (microneedling with topical human insulin solution.) — Zagazig University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| microneedling with topical human insulin solution. TARGET | microneedling with topical human insulin solution. | Zagazig University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- microneedling with topical human insulin solution. CI watch — RSS
- microneedling with topical human insulin solution. CI watch — Atom
- microneedling with topical human insulin solution. CI watch — JSON
- microneedling with topical human insulin solution. alone — RSS
Cite this brief
Drug Landscape (2026). microneedling with topical human insulin solution. — Competitive Intelligence Brief. https://druglandscape.com/ci/microneedling-with-topical-human-insulin-solution. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab